PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, NYU Grossman School of Medicine, New York, NY, United States.\', \'Department of Medicine, NYU Grossman School of Medicine, New York, NY, United States.\', \'NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, NY, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.797589
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35350781
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all